Replies to post #101549 on Biotech Values

[DewDiligence]

CELG—an unknown company is challenging the Revlimid patent:

http://finance.yahoo.com/news/Celgene-Expects-to-Receive-a-bw-4165458972.html?x=0&.v=1

[DewDiligence]

Identity of Revlimid-patent challenger revealed to be Natco:

http://www.reuters.com/article/idCNN0326933120100903

#msg-53738423 is a good background read on how CELG intends to maintain Revlimid exclusivity.

p.s. Natco is the Indian company that thinks it can make a generic Copaxone for the US market (#msg-29902618, #msg-52598947).